GENETICS OF BONE STRENGTH IN MEN

男性骨骼强度的遗传学

基本信息

  • 批准号:
    7606376
  • 负责人:
  • 金额:
    $ 3.41万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-12-01 至 2007-11-30
  • 项目状态:
    已结题

项目摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Age-related oateoporotic fracture, particularly hip fracture, is a major health problem in the United States and worldwide. Age-related decrease in bone strength is a major risk factor for osteoporotic fracture. Components of bone strength are highly heritable, and in our studies using premenopausal sister pairs, we have detected linkage to several measures of both bone mass and bone structure. Heritability studies on measure of bone strength in men are very limited. Furthermore, studies in mice suggest that sex specific genes may underlie differences in bone strength between men and women. The hypothesis that will be tested in this study is that in men bone mass, bone structure , bone quality and bone turnover have components that are genetically determined and are similar in magnitude to those we have established in women. However, while many loci will be the same in both sexes, certain loci will be sex specific. The skeletal sites that are being measured by dual X-ray absorptiometry are right femoral neck, trochanter and wards, lumbar vertebrae L2 to L4 and total body. Radiographs of the lower pelvis with upper femura in 15 degrees internal rotation are taken on standard X-ray equipment. All structural measurements are made on the right hip (the same measured by DXA) using a digital caliper. Fasting blood and urine will be collected for measurement of calcium regulating hormones and biochemical markers of bone turnover. Anthropometrics are measured on dedicated instruments; total body lean and fat are measured by DXA. The questionnaires include personal, family and medical history, medication history, smoking, physical activity and dietary questionnaires. All questionnaires have been verified and have been use over the last five years in GCRC Protocol 578.
这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者(PI)可能从另一个NIH来源获得了主要资金, 因此可以在其他CRISP条目中表示。所列机构为 中心,但不一定是研究者所在的机构。 骨质疏松性骨折,特别是髋部骨折,是美国和世界范围内的主要健康问题。骨质疏松相关的骨强度下降是骨质疏松性骨折的主要危险因素。骨强度的组成部分是高度遗传的,在我们使用绝经前姐妹对的研究中,我们发现了与骨量和骨结构的几种测量方法的联系。关于男性骨强度的遗传度研究非常有限。此外,对小鼠的研究表明,性别特异性基因可能是男女骨骼强度差异的基础。本研究将检验的假设是,男性骨量、骨结构、骨质量和骨转换具有遗传决定的成分,并且在数量上与我们在女性中建立的相似。然而,虽然许多基因座在两性中是相同的,但某些基因座是性别特异性的。通过双能X线吸收测定法测量的骨骼部位为右股骨颈、转子和Wards、腰椎L2至L4和全身。在标准X线设备上拍摄骨盆下部和股骨上部内旋15度的X线片。使用数字卡尺在右髋上进行所有结构测量(与DXA测量的相同)。将收集空腹血液和尿液,用于测量钙调节激素和骨转换的生化标志物。人体测量是在专用仪器上测量的;全身瘦和脂肪是通过DXA测量的。问卷包括个人、家庭和病史、用药史、吸烟、体力活动和饮食问卷。所有调查问卷均经过验证,并在GCRC第578号方案中使用了五年。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MUNRO PEACOCK其他文献

MUNRO PEACOCK的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MUNRO PEACOCK', 18)}}的其他基金

THE EFFECT OF GENISTEIN AND ISOFLAVONE METABOLITES ON CALCIUM ABSORPTION AND
染料木黄酮和异黄酮代谢物对钙吸收和吸收的影响
  • 批准号:
    7717567
  • 财政年份:
    2007
  • 资助金额:
    $ 3.41万
  • 项目类别:
GENETICS OF BONE LOSS AT THE HIP IN WOMEN
女性臀部骨质流失的遗传学
  • 批准号:
    7606377
  • 财政年份:
    2006
  • 资助金额:
    $ 3.41万
  • 项目类别:
THE EFFECT OF GENISTEIN AND ISOFLAVONE METABOLITES ON CALCIUM ABSORPTION AND
染料木黄酮和异黄酮代谢物对钙吸收和吸收的影响
  • 批准号:
    7606470
  • 财政年份:
    2006
  • 资助金额:
    $ 3.41万
  • 项目类别:
GENETICS OF BONE LOSS AT THE HIP IN WOMEN
女性臀部骨质流失的遗传学
  • 批准号:
    7205753
  • 财政年份:
    2005
  • 资助金额:
    $ 3.41万
  • 项目类别:
GENETICS OF BONE STRENGTH IN MEN
男性骨骼强度的遗传学
  • 批准号:
    7379055
  • 财政年份:
    2005
  • 资助金额:
    $ 3.41万
  • 项目类别:
GENETICS OF BONE LOSS AT THE HIP IN WOMEN
女性臀部骨质流失的遗传学
  • 批准号:
    7379056
  • 财政年份:
    2005
  • 资助金额:
    $ 3.41万
  • 项目类别:
A RANDOMIZED DOUBLE-BLIND STUDY TO EVALUATE AMG 162 IN THE PREVENTION OF
评估 AMG 162 预防疾病的随机双盲研究
  • 批准号:
    7379139
  • 财政年份:
    2005
  • 资助金额:
    $ 3.41万
  • 项目类别:
GENETICS OF BONE LOSS AND BONE STRENGTH IN WOMEN & MEN
女性骨质流失和骨质强度的遗传学
  • 批准号:
    7020553
  • 财政年份:
    2005
  • 资助金额:
    $ 3.41万
  • 项目类别:
GENETICS OF BONE STRENGTH IN MEN
男性骨骼强度的遗传学
  • 批准号:
    7205752
  • 财政年份:
    2005
  • 资助金额:
    $ 3.41万
  • 项目类别:
DNA STORAGE AND ANALYSIS IN METABOLIC BONE DISEASE
代谢性骨疾病中的 DNA 存储和分析
  • 批准号:
    7205738
  • 财政年份:
    2005
  • 资助金额:
    $ 3.41万
  • 项目类别:

相似海外基金

Repurposing rifampin to reduce elevated levels of blood and urine calcium in patients with inactivating mutations of CYP24A1
重新利用利福平可降低 CYP24A1 失活突变患者的血钙和尿钙水平升高
  • 批准号:
    10581278
  • 财政年份:
    2022
  • 资助金额:
    $ 3.41万
  • 项目类别:
The Relevance of Arterial Stiffness and Vascular Calcium to Blood Pressure and LV Structure and Function.
动脉僵硬度和血管钙与血压以及左心室结构和功能的相关性。
  • 批准号:
    9922348
  • 财政年份:
    2019
  • 资助金额:
    $ 3.41万
  • 项目类别:
The Relevance of Arterial Stiffness and Vascular Calcium to Blood Pressure and LV Structure and Function.
动脉僵硬度和血管钙与血压以及左心室结构和功能的相关性。
  • 批准号:
    10188614
  • 财政年份:
    2019
  • 资助金额:
    $ 3.41万
  • 项目类别:
Novel liquid embolic materials for brain endovascular therapy: natural polymer composite activated by blood calcium ions
用于脑血管内治疗的新型液体栓塞材料:血钙离子激活的天然高分子复合材料
  • 批准号:
    17H02080
  • 财政年份:
    2017
  • 资助金额:
    $ 3.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Repurposing rifampin to reduce elevated levels of blood and urine calcium in patients with inactivating mutations of CYP24A1
重新利用利福平可降低 CYP24A1 失活突变患者的血钙和尿钙水平升高
  • 批准号:
    9388011
  • 财政年份:
    2017
  • 资助金额:
    $ 3.41万
  • 项目类别:
Repurposing rifampin to reduce elevated levels of blood and urine calcium in patients with inactivating mutations of CYP24A1
重新利用利福平可降低 CYP24A1 失活突变患者的血钙和尿钙水平升高
  • 批准号:
    9980393
  • 财政年份:
    2017
  • 资助金额:
    $ 3.41万
  • 项目类别:
The paradox of calcium in bone and blood vessel induced by FGF23 signaling disruption
FGF23信号破坏导致骨骼和血管中钙的悖论
  • 批准号:
    17K17079
  • 财政年份:
    2017
  • 资助金额:
    $ 3.41万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Repurposing rifampin to reduce elevated levels of blood and urine calcium in patients with inactivating mutations of CYP24A1
重新利用利福平可降低 CYP24A1 失活突变患者的血钙和尿钙水平升高
  • 批准号:
    10170333
  • 财政年份:
    2017
  • 资助金额:
    $ 3.41万
  • 项目类别:
Rifampin to reduce elevated levels of blood and urine calcium in patients with inactivating mutations in the CYP24A1 gene
利福平可降低 CYP24A1 基因失活突变患者升高的血钙和尿钙水平
  • 批准号:
    350582
  • 财政年份:
    2016
  • 资助金额:
    $ 3.41万
  • 项目类别:
    Operating Grants
Development of whole heart calcium imaging system with two different waves using modified G-CaMP-DsRed-coexpressed transgenic rat model in the blood-perfused excised heart preparation
在血液灌注离体心脏制备中使用改良的 G-CaMP-DsRed 共表达转基因大鼠模型开发具有两种不同波的全心钙成像系统
  • 批准号:
    25460283
  • 财政年份:
    2013
  • 资助金额:
    $ 3.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了